|1.||Isaacs, David: 3 articles (08/2015 - 06/2008)|
|2.||Erdeve, Omer: 3 articles (01/2015 - 05/2011)|
|3.||Saygan, Sibel: 3 articles (01/2015 - 05/2011)|
|4.||Dilmen, Ugur: 3 articles (01/2015 - 05/2011)|
|5.||Segal, Esther: 3 articles (07/2012 - 12/2003)|
|6.||Khan, Masood A: 3 articles (02/2006 - 02/2003)|
|7.||Johansen, H K: 3 articles (01/2002 - 01/2000)|
|8.||Blyth, Christopher C: 2 articles (08/2015 - 09/2012)|
|9.||Mohamadi, Jasem: 2 articles (01/2015 - 01/2014)|
|10.||Luo, Yongzhang: 2 articles (01/2015 - 06/2011)|
07/01/2009 - "The introduction of a prophylactic nystatin administration policy for babies born before 33 weeks was associated with a significant reduction in fungal colonisation and invasive fungal infection."
05/01/1996 - "Nystatin treatment significantly reduced the frequency of multiple-site colonization and of persistently positive oropharyngeal cultures, but was not able to prevent the occurrence of disseminated fungal infections. "
04/01/1980 - "The trial showed that nystatin and micromazole were equallly effective in the treatment of vaginal yeast infection and that the broad-spectrum activity of micronazole offered no advantage in this condition."
06/01/2008 - "There is reasonable evidence that oral nystatin is effective in preventing fungal infections and at the same time it is inexpensive and well tolerated. "
10/01/1997 - "Based on these results in mice, it is probable that liposomal nystatin will be effective against Aspergillus infection in humans."
04/15/1978 - "[Case of pulmonary candidiasis treated successfully with nystatin administered orally and in inhalations]."
01/01/2008 - "Here, we studied the efficacy of a commercially available topical Nystatin suspension in a new ex-vivo model of candidiasis using porcine oral mucosa. "
10/01/1999 - "Safety and efficacy of multilamellar liposomal nystatin against disseminated candidiasis in persistently neutropenic rabbits."
05/01/1994 - "However, up to now, no study has correctly assessed the value of nystatin as a prophylactic agent against oropharyngeal candidiasis."
07/01/1959 - "[Chemotherapeutic studies on nystatin in experimental candidiasis in white mice]."
|3.||Oral Candidiasis (Thrush)
08/15/1996 - "In this small group of subjects, nystatin appeared to be effective in delaying onset of oral candidiasis. "
08/30/1986 - "Efficacy of a new nystatin formulation in oral candidiasis."
06/28/1986 - "Assessment of oral candidiasis in patients with respiratory disease and efficacy of a new nystatin formulation."
07/01/2010 - "SISA topical application, shows a comparable efficacy to the nystatin in the management of chronic oral candidiasis. "
12/01/2015 - "Two recipients who experienced thrush did not receive any nystatin. "
01/01/2015 - "reuteri supplementation is as effective as nystatin, and more effective in reducing the incidence of proven sepsis in addition to its favorable effect on feeding intolerance."
10/01/2013 - "Feeding intolerance, clinical sepsis, and number of sepsis attacks were significantly lower in the probiotics group than in the nystatin group. "
06/01/2015 - "These data demonstrate that a topical nystatin cream protocol is associated with a very low rate of Candida sepsis in ELBW infants with central catheters. "
06/01/2015 - "To evaluate the effectiveness of topical nystatin cream in preventing catheter-associated Candida sepsis. "
10/01/2013 - "boulardii supplementation is as effective as nystatin in reducing fungal colonization and invasive fungal infection, more effective in reducing the incidence of clinical sepsis and number of sepsis attacks and has favorable effect on feeding intolerance."
01/01/2013 - "Topical prophylaxis with nystatin and adequate source control proved to be effective in preventing invasive candidiasis in patients admitted to the NICU."
01/01/2015 - "reuteri) versus nystatin in prevention of fungal colonization and invasive candidiasis in very low birth weight infants. "
11/01/2006 - "Oral nystatin prophylaxis significantly reduced the invasive candidiasis (P = 0.004) in extremely low-birth weight (ELBW) and very low-birth weight (VLBW) infants. "
11/01/2006 - "To determine whether prophylactic oral nystatin results in a decreased incidence of invasive candidiasis in the newborn infants, a total of 3991 infants were divided randomly into two groups. "
11/01/2005 - "Oral nystatin prophylaxis efficiently prevented Candida spp. colonization in ICU patients at low risk of developing invasive candidiasis. "
|2.||Amphotericin B (Amphotericin)
|6.||Anti-Bacterial Agents (Antibiotics)
|8.||Trimethoprim-Sulfamethoxazole Combination (Co-Trimoxazole)
|1.||Drug Therapy (Chemotherapy)
|2.||Bone Marrow Transplantation (Transplantation, Bone Marrow)
|3.||Transplantation (Transplant Recipients)